India and France have jointly inaugurated the Indo-French Centre for AI in Health, a landmark initiative to accelerate collaborative research, technology development, and clinical applications of artificial intelligence in healthcare. The centre will serve as a hub for joint projects in AI-driven diagnostics, predictive modelling, drug discovery, and public health surveillance, strengthening bilateral cooperation and positioning both nations as leaders in responsible, impactful AI for global health challenges.
Glimpse:
Launched on January 25, 2026, during the India-France Technology Summit in New Delhi, the Indo-French Centre for AI in Health brings together leading institutions such as AIIMS, IITs, INRIA (France), and French university hospitals. It will focus on high-priority areas including AI for tuberculosis and cancer screening, maternal and child health analytics, antimicrobial resistance prediction, and ethical AI frameworks. Initial funding comes from both governments and industry partners, with plans for joint PhD programmes, technology transfer, and pilot deployments in India and France within the next 18–24 months.
India and France have taken a major step forward in their strategic partnership with the formal launch of the Indo-French Centre for AI in Health, a collaborative platform dedicated to advancing artificial intelligence applications in healthcare. The centre was inaugurated on January 25, 2026, during the high level India-France Technology Summit in New Delhi, attended by senior ministers, scientists, and industry leaders from both nations.
The initiative builds on longstanding bilateral cooperation in science and technology, now elevated to address pressing global health challenges through AI. The centre will operate as a virtual and physical network, linking premier Indian institutions including AIIMS Delhi, IIT Delhi, IIT Madras, and ICMR with French counterparts such as INRIA, INSERM, and leading university hospitals in Paris and Lyon. It will serve as a hub for joint research projects, talent exchange, technology co-development, and clinical validation studies.
Key focus areas include:
- AI-powered early detection and screening for high burden diseases (tuberculosis, breast cancer, diabetic retinopathy)
- Predictive modelling for antimicrobial resistance and outbreak forecasting
- Personalised medicine and genomics guided therapies
- Maternal, newborn, and child health analytics for low resource settings
- Ethical AI frameworks, bias mitigation, and data governance aligned with both countries’ regulatory environments
The centre will facilitate multi-institutional projects, joint PhD and postdoctoral programmes, faculty exchanges, and shared access to high performance computing resources. It will also support technology transfer, start up incubation, and pilot deployments in real world settings both in India’s public health system and France’s universal healthcare framework.
French delegation lead added: “France and India share a vision of AI as a force for inclusive health progress. This centre will enable us to co-create solutions that benefit not only our two nations but the world especially in areas like antimicrobial resistance and maternal health.”
Initial funding has been committed by both governments through the Indo-French Centre for the Promotion of Advanced Research (CEFIPRA) and aligned national programmes (IndiaAI Mission, France 2030 Health Innovation Plan). Industry partners from both countries are expected to join with co-funding and in kind contributions.
The centre’s first joint projects are already underway, including AI tools for TB screening in high-burden districts and predictive models for sepsis in neonatal ICUs. Results from these pilots will inform scalable deployment and policy recommendations in both nations.
“AI has the power to transform healthcare, but only if developed collaboratively and responsibly. The Indo-French Centre for AI in Health is our shared commitment to making that transformation inclusive, ethical, and impactful.”
By
HB Team
Related News
